Shares in Affymetrix dropped 9 percent for the five-day trading period ended Tuesday. The firm’s stock has been fluctuating between nearly $27 per share and $24 per share for the past couple of months. On Tuesday, Affy’s stock closed at $24.44, its lowest point since closing at $24.21 on May 17.
 
Shares in Caliper Life Sciences rose 8.7 percent for the tracking period. The firm’s stock has risen steadily over the past three weeks.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.